Dr. Kneeland Youngblood - 10 Jun 2025 Form 4 Insider Report for Light & Wonder, Inc. (LNW)

Role
Director
Signature
/s/ James Sottile, attorney-in-fact for Dr. Kneeland Youngblood
Issuer symbol
LNW
Transactions as of
10 Jun 2025
Net transactions value
$0
Form type
4
Filing time
11 Jun 2025, 16:27:16 UTC
Previous filing
06 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
YOUNGBLOOD DR KNEELAND Director C/O LIGHT & WONDER, INC., 6601 BERMUDA ROAD, LAS VEGAS /s/ James Sottile, attorney-in-fact for Dr. Kneeland Youngblood 11 Jun 2025 0001137820

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LNW Restricted Stock Units Award $0 +2,391 $0.000000 2,391 10 Jun 2025 Common Stock 2,391 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units are scheduled to vest on the earlier of (a) the date of the issuer's 2026 annual meeting of stockholders and (b) June 10, 2026. Each unit converts into a share of common stock on a one-for-one basis.